These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2015712)

  • 1. Detection of the terminal fluid-phase complement complex, SC5b-9, in the plasma of patients with insulin-dependent (type I) diabetes mellitus. Relation to increased urinary albumin excretion and plasma von Willebrand factor.
    Triolo G; Giardina E; Casiglia D; Scarantino G; Bompiani GD
    Clin Exp Immunol; 1991 Apr; 84(1):53-8. PubMed ID: 2015712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of SC5b--9 complement complex in plasma and synovial fluid of patients with rheumatic disease.
    Rus V; Malide D; Boloşiu HD; Parasca I; Duţu AL
    Med Interne; 1990; 28(4):305-10. PubMed ID: 2100875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J; Schramm L; Wanner C; Mulzer E; Henrich HA; Langer R; Heidbreder E
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Terminal complement complex (TTC) levels in plasma and urine from glomerular diseases: enzyme-linked immunosorbent assay (ELISA) using monoclonal antibody against neoantigens of TCC].
    Kusunoki Y
    Hokkaido Igaku Zasshi; 1990 Jan; 65(1):74-85. PubMed ID: 2328949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII).
    Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J
    Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Demonstration of apoptosis-associated cleavage products of DNA, complement activation products SC5b-9 and C3d/dg, and immune complexes CIC-C3d, CIC-IgA, and CIC-IgG in the urine of patients with membranous glomerulonephritis.
    Kotnik V; Premzl A; Skoberne M; Malovrh T; Kveder R; Kaplan-Pavlovcic S; Kotnik A; Stiblar-Martincic D
    Croat Med J; 2003 Dec; 44(6):707-11. PubMed ID: 14652883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of plasma terminal SC5b-9 complement complex in patients with pregnancy induced hypertension].
    Shangguan B; Huang X; Zhang C
    Zhonghua Fu Chan Ke Za Zhi; 1999 Jul; 34(7):409-11. PubMed ID: 11360651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo clearance studies of the terminal fluid-phase complement complex in rabbits.
    Hugo F; Berstecher C; Krämer S; Fassbender W; Bhakdi S
    Clin Exp Immunol; 1989 Jul; 77(1):112-6. PubMed ID: 2766574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relations between von Willebrand factor, markers of oxidative stress and microalbuminuria in patients with type 2 diabetes mellitus.
    Ibrahim HA; El-Meligi AA; Abdel-Hamid M; Elhendy A
    Med Sci Monit; 2004 Mar; 10(3):CR85-9. PubMed ID: 14976459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microalbuminuria in insulin dependent diabetes mellitus.
    Patel KL; Mhetras SB; Varthakavi PK; Merchant PC; Nihalani KD
    J Assoc Physicians India; 1999 Jun; 47(6):589-95. PubMed ID: 10999154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated terminal complement in cerebrospinal fluid in Guillain-Barré syndrome and multiple sclerosis.
    Sanders ME; Koski CL; Robbins D; Shin ML; Frank MM; Joiner KA
    J Immunol; 1986 Jun; 136(12):4456-9. PubMed ID: 3711661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the prevalence and associated features of abnormal albumin excretion in insulin-dependent and non-insulin-dependent diabetes.
    Marshall SM; Alberti KG
    Q J Med; 1989 Jan; 70(261):61-71. PubMed ID: 2594949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttransfusion anaphylactic reactions in a patient with severe von Willebrand disease: role of complement and alloantibodies to von Willebrand factor.
    Bergamaschini L; Mannucci PM; Federici AB; Coppola R; Guzzoni S; Agostoni A
    J Lab Clin Med; 1995 Mar; 125(3):348-55. PubMed ID: 7897302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired vascular function during short-term poor glycaemic control in Type 1 diabetic patients.
    Sørensen VR; Mathiesen ER; Clausen P; Flyvbjerg A; Feldt-Rasmussen B
    Diabet Med; 2005 Jul; 22(7):871-6. PubMed ID: 15975101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor in diabetic retinopathy.
    Abayomi EA; Miller E; Paton RC
    Cent Afr J Med; 1996 Jul; 42(7):205-6. PubMed ID: 8936786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction, ambulatory pulse pressure and albuminuria are associated in Type 2 diabetic subjects.
    Knudsen ST; Jeppesen P; Frederiksen CA; Andersen NH; Bek T; Ingerslev J; Mogensen CE; Poulsen PL
    Diabet Med; 2007 Aug; 24(8):911-5. PubMed ID: 17559428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to albumin in the plasma of patients with diabetes mellitus. Relationship with circulating immune complexes.
    Triolo G; Giardina E; Rinaldi A; Seddio G; Bompiani GD
    J Clin Lab Immunol; 1986 Nov; 21(3):113-5. PubMed ID: 3560190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated circulating P-selectin in insulin dependent diabetes mellitus.
    Jilma B; Fasching P; Ruthner C; Rumplmayr A; Ruzicka S; Kapiotis S; Wagner OF; Eichler HG
    Thromb Haemost; 1996 Sep; 76(3):328-32. PubMed ID: 8883265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [ELISA for detection of SC5b-9 levels in plasma and its clinical significance in SLE disease].
    Kan D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Aug; 15(4):302-5. PubMed ID: 8168211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Terminal complement complex in plasma from patients with systemic lupus erythematosus and other glomerular diseases.
    Horigome I; Seino J; Sudo K; Kinoshita Y; Saito T; Yoshinaga K
    Clin Exp Immunol; 1987 Nov; 70(2):417-24. PubMed ID: 3427827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.